David Babbitt is a Cardiology physician. OpenAlex indexes 6 publications with 299 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3000 Mack Rd # 100
Fairfield, OH 450145335
Telephone
513-751-4222Registry record last updated 1 Apr 2015.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.1%Statin21.9%Atorvastatin Calcium50%Rosuvastatin Calcium36%Pravastatin Sodium9%Simvastatin4%Part D<11 patientsBeta blocker20.8%Metoprolol Succinate39%Carvedilol29%Metoprolol Tartrate25%Atenolol8%Part D≥59 patients+ 12 more classes in this area
Blood & clotting
18.2%P2Y12 inhibitor9%Clopidogrel100%Part D≥78 patientsFactor Xa inhibitor8.3%Eliquis55%Xarelto45%Part D≥27 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.7%Potassium supplement1.7%Potassium Chloride58%Klor-Con M2042%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical significance of terminal QRS abnormalities in the setting of inferior myocardial infarction
Journal of Electrocardiology
1991 - Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical.
PubMed
1990 - Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angiopiasty
Journal of the American College of Cardiology
1988
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”